[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"oral-dysesthesia\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:oral-dysesthesia":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100631848","mucolock-for-treatment-of-stomatitis-100631848",false,"NCT07506018","MucoLock™ for Treatment of Stomatitis","A Phase II Open-Label Trial of MucoLock™ Oral Rinse for the Treatment of Stomatitis Characterized by Oral Dysesthesia","Inclusion Criteria:\n\n* Age 18 years and older\n* Individuals with oral dysesthesia (worst VAS sensitivity\u002Fburning score ≥ 7 over the last week)\n* Ability to understand and the willingness to sign a written informed consent document\n\nExclusion Criteria:\n\n* Inability to comply with study instructions\n* Uncontrolled intercurrent illness or psychiatric illness\u002Fsocial situations that would limit compliance with study requirements\\*\n* Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the participant or the quality of the data.\n* Advanced kidney disease\n* Patients receiving antineoplastic therapy \\[e.g., tyrosine kinase inhibitors (TKIs), radiation\\] that could increase the risk of oral dysesthesia\n* Known altered mental status, encephalopathy, or cognition impairment\n* Ataxia\n* Known alcohol use disorder\n* Concomitant opioid therapy\n* Diagnosis of oral cancer currently undergoing therapy\n* Already using topical therapy for mouth pain (e.g., lidocaine, Magic mouthwash)\\*\n* Any opioid pain medication\\*\n* Treatment with another investigational drug or other intervention within 2 weeks. Patients will be recommended to stop previous medication for 2 weeks before starting the study treatment.\n\n(asterisk) \\*Modifiable criteria, with a timeframe of 2 weeks for a washout period.","ALL","18 Years",{"count":19,"type":20},25,"ESTIMATED","INTERVENTIONAL",[23],"NA","The purpose of this research is to test how well people can tolerate MucoLock™ as a treatment for mouth pain or burning sensation and how well it works to reduce mouth pain or burning sensation. Study participants will be asked to use MucoLock™ topical solution as a \"swish and spit\" solution (similar to mouthwash) three times per day for 5 minutes each time, for 28 days.",[26,27,28,29,30],"Stomatitis","Pain","Burning Mouth","Burning Mouth Syndrome","Oral Dysesthesia","RECRUITING","2026-04-16",{"date":34,"type":35},"2026-04-20","ACTUAL",{"date":37,"type":35},"2026-04-15",{"date":39,"type":20},"2028-05",{"name":41,"class":42},"Baptist Health South Florida","OTHER"]